(Q81896223)

English

CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome

scientific article published on 01 July 2005

Statements

CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit